Embryonal stem cells have been shown to differentiate in vitro into all hematopoietic lineages. This has been used successfully as one approach to the study of genetic events occurring during haematopoiesis. However, studies on the commitment of mesodermal precursors to the hematopoietic lineage have been limited due to the inability to define a system in which embryonal stem (ES) cells will give rise to primitive hematopoietic stem cells in vitro. Using a colony forming assay (CFU-A), we determined that the earliest time point at which primitive multilineage hematopoietic precursors can be detected during ES cell differentiation in vitro in the absence of exogenous conditioned medium or stromal cell culture is 4 days. Lethally irradiated adult recipient mice that received differentiated ES cells from this time point HE HEMATOPOIETIC system is a complex developmental system consisting of lymphoid, myeloid, and erythroid elements, which can be shown experimentally to be derived from a single multipotent stem cell.' Cells within this system are regulated by a range of growth factors2 that control both proliferative and differentiative processes. Little is known of the precise nature of the inter-and intra-cellular signals involved in control of hematopoietic differentiation of the earliest hematopoietic stem celk3 These cells remain difficult to analyze because of their low frequency in hematopoietic tissues and their paucity of specific markers. For example, in the mouse long-term repopulating cells exist in the marrow at a frequency of 1 or 2 X lo5 cells4 and are a small fraction of the progenitor population that is defined by the absence of lineage markers and expression of Thy-l Sca-1 and lectin binding receptor^.^ In the human, putative longterm repopulating stem cells are similarly defined (but not exclusively) by the absence of lineage markers and the specific phenotype, CD34' CD38-HLADr-.6 Highly pluripotent human hematopoietic stem cells (HSC) can be defined biologically by their ability to repopulate bone marrow ablated recipients over the long term, but their presence is only inferred. In mice, groups of stem cells that have selfrenewing and more transient repopulation ability can be as- 
sayed in vivo by the spleen colony assay or by a variety of equivalent in vitro clonal assays, which rely on addition of various growth factors and cytokines.
The differentiation of hematopoietic stem cells from embryonal stem (ES) cells in vitro may hold the key to the problem of generating sufficient and accessible numbers of highly pluripotent HSC to analyze the genetic control of their differentiation. ES cells are totipotent cells derived from the inner cell mass of 3.5 day murine blastocysts7 and maintained in their totipotent state in vitro in the presence of the cytokine DIALIF.' The capacity of ES cells to contribute to all embryologic lineages in the developing mouse'.'" is mimicked in vitro after removal of DIALIF, which stimulates ES cell differentiation into a range of embryonic cell types including those of myogenic, neuronal, and hematopoietic lineages. When ES cells are cultured as aggregates or embryoid bodies (EBs) and then allowed to differentiate, hematopoiesis is routinely observed as islands of hemoglobinized erythroid cells, or blood islands, within the developing EBs." These structures contain progenitor cells capable of giving rise to cell types from myeloid, erythroid, and lymphoid lineage^.""^ PCR studies have also demonstrated the expression of a range of hematoregulatory cytokines and their receptors within the developing EBs.'~"~ More recently a broad spectrum of mouse hematopoietic differentiation has been achieved by growth of ES cells on a feeder layer derived from bone marrow stroma of the op/op (osteoperotic) mutant." It is reasonable to assume that during EB differentiation, ES cells transit through an HSC phenotype, identification and amplification of which may provide a target for genetic and physiologic analysis and modification. A more precise phenotypic examination of such manipulated stem cells would be made possible by their efficacy in the reconstitution of the hematopoietic system of, for example, sublethally irradiated mice. Several workers have reported ESderived repopulation in restricted lineage^.'^,'^ A recent report has suggested that HSC can be isolated from differentiating ES cells.'" These workers demonstrated multilineage reconstitution at a relatively high level, which appeared to be dependent on stromal cell co-culture of differentiating ES cells." However, the use of this co-culture system has two possible problems; identification of the time points critical to HSC commitment was not described, and the use of exogenous cytokines/stromal cell layers may or may not be more likely to perturb the normal differentiation program of the totipotential ES cells. If it were possible to more closely define the time course of hematopoietic commitment and to rely on endogenous ES cell driven differentiation, then this may b e a more suitable system for identifying genes and gene products that could regulate the commitment to and differentiation from HSC.
We report here evidence that ES cell differentiation in vitro in the absence of conditioned medium or stromal cell culture can give rise to multilineage repopulating hematopoietic progenitors. Using an in vitro assay for the detection of primitive hematopoietic progenitors (the CFU-A assay) we have characterized the earliest time points at which hematopoietic commitment can be detected. On the basis of this information, a critical and transient time point was identified at which cells capable of multilineage hematopoietic reconstitution of lethally irradiated adult recipient mice were present. Rescue of lethally irradiated mice could be uncoupled from reconstitution by injection of ES-derived progeny from different stages of differentiation. Analysis of gene expression at this time point has identified candidate genes that could be used to further characterize the molecular and cellular events occumng in early hematopoietic commitment.
MATERIALS AND METHODS

ES Cell Culture and Embryoid Body Formation
The ES cell line EFC-1" was routinely passaged and maintained in an undifferentiated state as described.22 All experiments described used EFC-I cells of less than 30 passages showing no evidence of aneuploidy. EBs were formed as de~cribed.'~ In brief, ES cells were cultured in hanging drops (10 pL) at a concentration of 3 X lo4 cells/mL in the presence of leukemia inhibitory factor (LIF) for 48 hours in a humidified 5% CO2 atmosphere. ES cell aggregates were harvested into a petri dish (IO3 aggregated10 mL ES cell culture medium lacking LIF) and allowed to differentiate for varying periods of time (up to 35 days). Medium was replaced every 2 days.
The CFU-A Assay
The in vitro CFU-A assay was set up as described previo~sly.*~~'~ Briefly, a feeder layer consisting of 0.6% agar in a-modified Eagle's medium ((U-MEM) with conditioned medium from two cell lines (AFI-19T; a source of granulocyte macrophage colony-stimulating factor [GM-CSF]; and L929; a source of CSF-I) was poured into 3 cm diameter tissue culture grade dishes (1 mL per layer). Embryoid bodies (intact or homogenized) were added to 0.3% agar in a-MEM and added to form an upper layer. The dishes were incubated for 11 days at 37°C in a humidified atmosphere with 5% 02/10% COz. EBs were plated out either intact (50 EB/plate) or following disruption with trypsin (0.05%) in PBSEDTA (1 mmol/L) for 30 minutes at 37°C (lo5 cells/plate).
Clonal analysis of CFU-A from the bone marrow of transplanted mice was camed out by plating into 96 well dishes at 400 cells/ well, using 50 pL/well of feeder and upper layers. Agar concentrations were reduced to 0.3% and 0.15% for the feeder and upper layers, respectively.
The responsiveness of the cells giving rise to hematopoiesis in the CFU-A assay to SCVMIP-la, a previously described stem cell inhibitor,26 was tested by its direct addition to the underlay in the CFU-A assay plates. Inhibition was assessed by the ability of SCI/ MIP-la to block formation of hematopoietic colonie~.'~
Replating Studies
Colonies forming from EBs in the CFU-A assay were picked at day 7 and disaggregated by vigorous pipetting in 100 mL of a-MEM. Single cell suspensions from both EB-derived hematopoietic colonies and intact EBs were replated under the same CFU-A culture conditions. One colony was replated in a single dish and the extent of disaggregation of the colonies assessed microscopically to ensure that no cell clumps could have mistakenly been scored as secondary colonies. Secondary colonies generated in this way were scored at day 11 as macroscopic colonies ( > l mm diameter) and clusters consisting of >50 cells but with a diameter of < l mm.
Reconstitution of Irradiated Recipient Mice
For reconstitution, EBs were harvested and disaggregated with dispase (1 U/mL; Boehringer Mannheim, Lewes, UK) in phosphatebuffered saline (PBS), washed and injected intravenously (lo6 cells in 0.4 mL PBS; approx 200 EB equivalents) into lethally irradiated (10.5 Gy) female 129/01a or CBN129 F1 mice after mixing with a limiting dose of autologous (female) spleen carrier cells (5 X lo5).
Mice were maintained on Neomycin sulphate (Sigma, Poole, UK) drinking water to control for opportunistic infection. After 3 weeks, retro-orbital blood samples were collected at intervals. Selected samples were sorted into lymphoid and myeloid components on the basis of their forward and right angle scatter andlor their expression of lymphoid and myeloid markers on a Becton Dickinson FACstar Plus fluorescence activated cell sorter as described.'* The proportion of peripheral blood leukocytes from whole blood and after sorting that were derived from male ES cells was determined by PCR essentially as described,29 with the exception that ZFY and Myogenin reactions were carried out in separate tubes for 25 cycles and that the PCR temperature profile for myogenin was as follows: 94°C for 5 seconds, 60°C for 30 seconds, and 72°C for 30 seconds. PCR products were run on 2% agarose gels, Southern blotted, and probed with ZFY or myogenin 32P-labeled probes as appropriate. "P label associated with bands on the blots was quantitated either directly using a phosphoimager (Molecular Dynamics, Chesham, UK) or bands were excised from the blot and label counted on a Packard 8-counter. Results are expressed as 32P CPM ZFY/myogenin ratios. In experiment 3, half of the recipient mice were CBN129 F1 and half 129/01a. There was no obvious difference between these groups; results shown are pooled from both sets.
PCR
One microgram of total RNA, isolated using RNAzol B (Biotecx), was reverse transcribed using AMV reverse transcriptase (Promega) according to the manufacturer's instructions. Random oligo hexamers (Boehringer) were used as primers. PCR reactions were then carried out essentially as described16 except for the variations listed in Table 1 . PCR products were run on 2% agarose gels and stained with ethidium bromide. Results were assessed on the presence or absence of the appropriately sized PCR products. RNA controls were included to monitor genomic contamination.
RESULTS
Intact EB-Derived Colonies
The ability of intact EBs to form colonies in the C m -A assay was followed over a 2-week time course (Fig 1) AGAAlTCAACCAGACATGCACCTACC  GAGACAATGAGACCATCTGGGG  CCCCTACCCTGATGGAGTCTGT  TCTGTCCCTTTCACTCACTGGC  CTCCTCCGCTTGCAAATGTCAC  TTATATGTCGACGAGATGAGATGCAGG  CACAGGAGTGAACCAGAACA  CTCGTCGACGTCCCTGCAAGAT  CGCCATATGGAGCTGACACCCCGACTGCC  ACGACATCACAGTAGAGC   TAAGCTTATGGCGCAAGCCGGGAGAACAG  GAATCTGTCTGCCTGATGGAGC  GGATTAGAGCACCTACCTACCC  GATAGCAAATCGGCTGACGGTG  GGCGGAGTCTTCCCATTTCTGA  AAAATTGTCGACGCTCCAGTATATAAATC  TATAGTCGACGTCCTTGTAAGTACCCAC  GCTGGACAACTGGAAATTCAGG  TCAGGCAATCAGTTCCAGGTCAGT  GCCAGTTCTTCTACGTATCC   57  63  63  63  63  60  50  60  65  60   597  850  450  544  448  180  640  130  299  282 Other primer pairs and conditions are as described elsewhere.16 studies showed that CFU-A-like hematopoietic colonies started to appear around days 4 to 6 after removal from DIALIF. No substantial hematopoiesis as defined by colony formation was detectable before the 4 day time point and this temporal pattern of emergence of hematopoietic progenitors within the differentiating EBs was precise and reproducible.
In these experiments the cloning efficiency as defined by the percentage of plated EBs forming robust CFU-A-like hematopoietic colonies was often as high as 40% to 50% and in subsequent experiments has been noted as being as high as 70% to 80%. Colony size varied but the majority of colonies were macroscopic with a diameter of 2 mm or greater. These large colonies appeared to radiate out from the embryoid bodies and morphologic analysis revealed them to be essentially macrophage in composition, typical of the progenitor-derived colonies detected by this assay. Undifferentiated ES cells, either as aggregates or as cell suspensions, were unable to form hematopoietic colonies in the C m -A assay, indicating both the need for differentiation within the EB before CFU-A formation and the inability of the cytokines in the CFU-A assay to induce hematopoietic my. ot Dmor.nUaUon 
CFU-A Colony Formation by Isolated EB-Derived Hematopoietic Cells
CFU-A colony formation from intact EBs does not give any qualitative information about the size of colonies produced by individual clonogenic cells within the aggregates, nor does it indicate how many clonogenic cells were present within each EB. In order to address this, EBs were prepared as described above, enzymatically disrupted into single cell suspensions and plated out in the CFU-A assay (Fig 2) . Up to day 4 of differentiation, small tight colonies of residual undifferentiated ES cells were detected (data not shown). These colonies never went on to produce hematopoietic cells. Hematopoietic colonies were detected at 4 days of differentiation, a result consistent with data from intact EBs (Fig 1) . The diameter of colonies produced in the CFU-A assay is a measure of the multipotency of the clonogenic cell; small (<2 mm) colonies arise from committed Progenitors. We found that large (>2 mm) CFU-A colonies were typically detected early on in the differentiation process, although in some experiments, CFU-A colonies could be detected as late as 15 days of differentiation.
The number of colonies produced was relatively small in relation to the number of EBs plated out. When individual EBs were disrupted and plated out in CFU-A assay, those EBs that contained hematopoietic progenitors were shown to possess only one or two such cells (day 4 EB; n = 1.3 i-0.4; day 5 EB n = 1.5 5 0.5; day 6 EB n = 1.6 -t 0.5).
EB-Derived Hematopoietic Colonies Are the Progeny qf
CFU-A Like Cells
To investigate the provenance of the cells within the EBs that were responsible for the development of macroscopic colonies in the CFU-A assay, a number of characteristics of these cells, which are known hallmarks of bone marrow derived CFU-A progenitors, were investigated. Days 4 to 6 EBs were used for these studies. 
15+
Replating efficiency. The ability of cells within colonies EBs were collected following 4 days of suspension culture derived from primitive hematopoietic cells to produce secafter removal from DWLIF (d4 EB), dissaggregated, and inondary colonies on replating is well documented. Results jected intravenously into lethally irradiated (10.5 Gy) female from studies on the replating efficiency of the EB-derived mice after mixing with limiting doses of carrier female spleen colonies are outlined in Table 2 . These results show that the cells. ES progeny in the reconstituted mice were detected by majority (78%) of primary colonies formed from the EBs a polymerase chain reaction (PCR) based assay for detection were capable of forming secondary colonies following reof the male ZFY gene (see. Materials and Methods). A PCR plating under CFU-A assay conditions and that 30% to 40% assay to detect reconstitution has the advantage of speed and of these secondary colonies were macroscopic in nature and the small quantities needed for priming DNA. However, it can resembled the primary colonies. be poorly quantitative. Using 25 cycle PCR, we found that Responsiveness to a stem sell spec@ regulator. Results increasing the percentage of male cells in a female control from a titration of SCVMIP-la (a potent inhibitor of stem sample increased the zEy/Myo ratio in a broadly proportional cell proliferation/differentiation)26 in the CFU-A assay are manner (Fig 3) and the quantity of priming DNA over a 100-shown in Table 3 and indicate that the majority of EBfold range had little effect on this ratio (<lo% variation; data derived macroscopic colonies (70%) were inhibited from not shown). These data demonstrate that this assay provides a developing in the presence of this negative regulator, with semiquantitative measure of small proportions of male ES cells a half maximal inhibition being achieved at approximately 12.5 ng/mL, a value that is identical to that required to inhibit normal bone marrow derived CFU-A stem cells in vitro. 26 There appears to be a resistant subpopulation of EB-derived colonies that presumably represent more mature progenitor cells and do not respond to concentrations of SCI/MIP-la as high as 100 ng/mL. SCI/MIP-la has no effect on the growth of nonhematopoietic EBs in the CFU-A assay and appears therefore to be specific for primitive hematopoietic cells within the differentiating EBs. derived in female blood, which is sufficient to follow reconstitution with confidence.
In each of a series of three reconstitution experiments (Table 4 ) lethally irradiated mice that received both d4 EB cells and carrier spleen cells showed a substantial improvement in post-irradiation survival over those receiving spleen cells alone. Peripheral blood from mice that received d4 EB cells were found to contain ES-derived leukocytes (Table 4 and Fig 4A and B) although in one of the experiments (expt 2), this was restricted to a single time point in one mouse. There was variation in the level of reconstitution between Repopulation of Lethally Irradiated Mice with ES-Derived mice and Over time within individual mice ( Fig 4~) such Hematopoietic Precursors that interpretation of any trends in level of hematopoietic Having used the CFU-A assay as a simple detection sysreconstitution has to be circumspect. However, such recontern to define the time at which EBs contain primitive selfstitution may have increased from a very low level at 1 renewing hematopoietic progenitors, we have investigated month posttransplantation to as much as 20% to 30% of the ability of EB cells just before this time point (ie, d4 EBS) peripheral blood leukocytes of surviving mice at 6 months in to reconstitute the hematopoietic system of lethally irradiated experiment 1. In experiment 3 3 although derived Progeny adult mice. were detected over a 5-month period, the level of repopulation was no more than 5% (Fig 4D) . One interpretation of this data could be that ES-derived repopulating progenitors may be analogous to "fetal" HSC in their ability to compete out "adult" type HSC over time.30 Due to the greater propensity of fetal HSC to remain in quiescence,3' they can be present in greater numbers in bone marrow than the proportion of their progeny in the periphery would indicate. In order to investigate this possibility, bone marrow from ES transplanted mice was plated out at limiting dose in a 96 well CFU-A assay such that colonies were present in 39% of the wells. When DNA from colonies was tested with ZFY PCR, 6 of 80 (8.5%) were positive for male ZFY. Interestingly, the ZFY/MYO ratio for peripheral blood of that recipient suggested that ES-derived peripheral blood leukocytes were present at a level of 1% to 2% (data not shown).
HSC have the properties of both long-term reconstitution and multilineage repopulation. In order to determine in what lineages ES-derived progeny might be found, peripheral blood from transplanted animals was sorted into lymphoid and granulocyte populations by fluorescence activated cell sorting (FACS). In the first experiment this was on the basis of their forward and right-angle scatter characteristics** and the ES cell contribution to these populations was assessed by PCR. Contamination of one population by the other was <5% (data not shown). Peripheral blood from four of six recipient mice at 12 weeks posttransplantation contained both lymphocytes and granulocytes that were ES cell derived (Fig 5) . ES cell derived leukocytes were restricted to the lymphoid compartment in two of the animals. The possibilities that male ES-derived, but nonhematopoietic, cells were present in these gated populations or that gross contamination of one population by the other were giving artifactual results was addressed by FACS sorting of peripheral blood from mice in experiment 3. In two animals, sorting was on the basis of cell surface expression of CD45 (expressed on all circulating, nucleated bone marrow-derived cells) and the presence or absence of granulocyte markers (Fig 6) . Figure  6C and D shows that sorted cells that were either positive or negative for granulocyte markers were all CD45' and their forward and side scatter profiles were similar to those for granulocytes (high scattering) or lymphocytes, respectively (Fig 6E and F ) with between 98% and 99% punty. ES-derived hematopoietic progeny were detected in both these populations (myeloid and lymphoid lineage, respectively) at 9 weeks posttransplantation (Fig 7) .
PCR Analysis
It appeared that some EBs at day 4 of differentiation contained cells that were capable of reconstituting at least two discrete hematopoietic lineages. In order to make a preliminary determination of the genetic events that may control commitment at or around this time point, qualitative PCR analysis was carried out on reverse transcribed mRNA extracted from EBs at varying stages of differentiation ( Table  5 ). Given that our results for the reconstitution of animals differed from those published by Muller and Dzierzak,'' this RT-PCR analysis would further serve to highlight any differences in the differentiation processes described above and described else where."^'* Data in Table 5 show that markers of hematopoietic commitment tended to appear by day 8 of differentiation, with two notable exceptions: Thy-l and Ly-6 were detected in ES cells and globin; although undetectable at day 2, they began strong and persistent expression by day 4. Expression of several cytokines (IL-3, IL-6, G-CSF, GM-CSF, and M-CSF) was undetectable at the level of analysis adopted, but in contrast, the receptors for at least M-CSF, IL-3, and G-CSF were present. The inhibitory cytokines LIF and MIP-l a showed a reciprocal pattern of expression, with LIF (but not MIP-la) being expressed in undifferentiated EBs, and early EBs with MIP-la (but not LIF) only detectable in late (d12) EBs.
DISCUSSION
We have used the CFU-A assay to define the point at which ES cells enter a hematopoietic stem cell like phase in vitro. Our results indicate that between 4 and 6 days after release from the differentiation inhibiting activity of DIN LIF. EBs contain within them cells capable of forming macroscopic colonies in the CFU-A assay. Forty to sixty percent of differentiating EBs are capable of forming such colonies.
Those that do not demonstrate hematopoietic activity in primary CFU-A cultures can be shown to frequently contain hematopoietic colony-forming cells after disruption and replating into secondary CFU-A assays. Intriguingly we have found that once the EBs are disrupted, the component cell's ability to form colonies in primary CFU-A assays is very limited and in general, when colonies were formed they tended to be very small and diffuse. This is especially true of EBs that are disaggregated after 7 or more days of differentiation. These tended to produce smaller hematopoietic colonies in the CFU-A assay more typical of those derived from more committed progenitors, whereas the few colonies produced from d4-d6 EBs were predominantly of the large CFU-A type. More robust colonies tended to be associated with EB fragments that had escaped the homogenization process. Taken together these data suggest that both differentiation inhibiting and hematopoietic stimulating cytokines and/or niches? may be essential within the EB for the main- tenance and differentiation of primitive hematopoietic cells. These niches may include endogenous stromal or 'nurse' cell types analogous to those provided exogenously in previous studies that have reported the derivation of multilineage hematopoiesisix or HSC'" from ES cells in vitro. An alternative explanation for this phenomenon is that compaction of the ES cells during EB formation allows the EB to act as ;I coordinate unit and that disruption of this unit impairs "normal" developmental processes. There is abundant evidence from compaction deficient ES and teratocarcinoma cell line studies that such mutations severely impair normal differentiation.'" Our EB replating experiments and the demonstration that the colony-forming elements within EBs are sensitive to the stem cell specific inhibitory cytokine (SCVMIP-la) provide further evidence that colonies derived from EBs are relatively primitive self-renewing hematopoietic progenitors with considerable self-renewing potential. They are likely to be analogues of the CFU-A/CFU-S colony-forming cells identified by similar assays of mouse bone marrow.
We reasoned that since the CFU-A/CFU-S cell is likely to have transient engrafting potentialJ5 and that in our hands CFU-A were typically maximal in EBs by day 5, day 4 EBs were likely to be a source of hematopoietic progenitors that would have long-term repopulating ability. Repopulation studies were therefore concentrated on cells derived from EBs at around this time point, and they show that although control animals largely failed to survive the irradiation, substantial numbers of mice receiving the d4 EB cells were rescued from the lethal effects of the radiation treatment, regardless of the detectable presence or absence of ES-derived progeny. This rescue suggests potentiation of either endogenous stem cells or those present in the carrier hematopoietic cells, normally capable of only transient engraftment.
Few ES cell derived hematopoietic progeny were detected in the peripheral blood for 3 to 6 weeks after repopulation. The reasons why ES-derived hematopoietic reconstitution was not observed in the second experiment were unclear. However. CFU-A analysis of a sample of the embryoid bodies used for this repopulation revealed a paucity o f CFU-A compared with other experiments (data not shown). This. along with the observation that the number of hematopoietic precursors within each committed ER is likely to be low (probably between I and 2 ) . suggest that too small a number of repopulation-competent cells may have been transplanted. Irradiation survival of the mice in experiment 2. however. was similar to that seen in other experiments. even in the absence of ES-derived reconstitution. Uncoupling of rescue from reconstitution in this way is reinforced by other experiments. Although we report here only data from transplantation of day 4 EBs. cells from day 6 ERs. although showing increased levels of hematopoiesis in vitro (Fig l ) . similarly rescued mice from lethal irradiation but failed t o contribute to detectable levels of hematopoiesis. The mechanisms underlying these provocative observations are currently under investigation. The initial results examining numbers of clonogenic progenitors i n the bone marrow would suggest that peripheral blood reconstitution may not be the most appropriate measure of the numbers of hematopoietic progenitors derived from ES cells in vitro.
These data indicate the presence of long-term repopulating cells within day 4 ERs. Our detection of ES markers in both lymphocytes and granulocytes in peripheral blood further underlines the pluripotent nature of the ER-derived hemntopoietic progenitors. Although the absence of clonal markers in these experiments do not rule out independent repopulation with granulocytic progenitors or lymphocytic progenitors, the short half-life of granulocytic precursors coupled with the increase in ES cell contribution over the time course of the experiment make it unlikely that two lineage restricted progenitors were co-in.jected.
Evidence from RT-PCR analysis of gene expression during EB differentiation suggests that there are no gross differences between the program of hematopoietic differentiation outlined here and that reported elsewhere.'"'" Markers of lymphoid commitment (CD2. CDS) were detected consistently from day 8 onward. This is supported by additional experiments that detected RAG-l expression from day 6 onward:"' and is consistent with the detection of lymphoid cells at later time points of EB differentiation by other investigators. The sharp onset of globin expression at day S is remarkable. in part because erythroid commitment a s mea- . , Both LIF and MIP-la have been shown to influence maintenance of hematopoietic stem cell^,^'.^* and were found in EBs in our program of differentiation. The possibility that these cytokines might influence the time course of hematopoietic commitment and/or numbers of hematopoietic progenitors derived from ES cells in vitro could be addressed by differentiation of double "knock out" ES cells. Given reports that expression of M-CSF can directly influence the hematopoietic commitment of ES cells in vitro,Ix it is interesting that although transcripts for M-CSF receptor were found, transcripts for ligand were undetected, although we cannot exclude the possibility of very low level expression.
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For personal use only. on October 27, 2017. by guest www.bloodjournal.org From In conclusion, therefore, the data presented here suggest that multipotent. long-term. repopulating hematopoietic progenitors may be transient within the EBs and developing at or around day 4 postdifferentiation initiation. This observation may suggest one explanation for the limited lineage reconstitution seen in other studies where ES cells were allowed to differentiate for extended periods before trans-HOLE ET AL plantation''."' and tends to negate the conclusions of Muller and Dzierzack'" that ES cell derived hematopoietic precursors are qualitatively different from those found in the adult. having the capacity to generate only the lymphoid lineage in transplanted adult mice, These workers used different ES cell lines to the one described here. Although we have seen reconstitution with other ES cell lines (E14TG2a and ZIN40. data not shown) we cannot exclude the possibility that the differentiation of long-term repopulating cells is cell line and/or passage number dependent. Our work supports the observations of others that have reported the derivation of multilineage repopulating hematopoietic progenitors from ES cells in vitro, with substantial ES-derived reconstitution in a hematopoiesis-defective mouse strain."' These workers reported the use of stromal cell lines and conditioned medium to enhance ES-derived hematopoiesis. Our results, along with the work of others, indicate that in the absence of exogenous stromal cells, intact embryoid body formation is a prerequisite for appropriate hematopoietic commitment by ES cells. It is entirely possible that the conditions of differentiation that we have used have allowed the differentiation of appropriate stromal or support cell types within the embryoid body. One approach to confirming this is to use whole mount in situ hybridization to examine the cell structures surrounding foci of hematopoiesis within the developing EB.
By relying on the endogenous differentiation machinery provided by the ER itself. we may have more clearly identi- 
